Aristotle University Of Thessaloniki (AUTH)
Νανο-τεχνολογική προσέγγιση καρκινικών βιοδεικτών
Abstract
dc:descriptionIn this dissertation, studies were conducted to develop new nanotechnological methods for detecting cancer biomarkers (mainly the DJ-1 protein) with the aim of early disease diagnosis and monitoring patients during their therapeutic treatment. Additionally, efforts were made to better understand the oncogenic role of the DJ-1 protein and its relationship with the prognosis of various types of cancers. The study investigated how immunotherapy with immune checkpoint inhibitors could affect serum levels of DJ-1 protein of cancer patients and if the DJ-1 could be used as a new predictive and prognostic cancer biomarker using current achievements in nanotechnology. Finally, we studied the levels of Short-Chain Fatty Acids (SCFAs) in the serum of cancer patients receiving immunotherapy and how these affect treatment responses. For the quantitative determination of the oncogenic protein DJ-1 in serum samples of cancer patients, was used the Enzyme Linked Immunosorbent Assay (ELISA) method, specifically the sub-method Sandwich ELISA. Statistical analysis of measurements was conducted based on various clinicopathological characteristics of patients and disease outcomes. Results between the classic ELISA method and Raman spectroscopy were compared, with Surface-Enhanced Raman Spectroscopy (SERS) being a particularly useful tool for precise molecular identification. In particular, the effect of surface-enhanced Raman (SERS), which substantially enhances the sensitivity of conventional Raman spectroscopy, was used by instilling blood serum and pure DJ-1 protein on metallic nanostructured plasmonic surfaces. For the determination of short-chain fatty acids, the Liquid Chromatography coupled with Tandem Mass Spectrometry (LC-MS/MS) method was used (Liquid Chromatography /Tandem Mass Spectrometry). According to our results, DJ-1 protein could be used as a biomarker related to histological type (adenocarcinoma), primary site (gynecological cancer), some clinicopathological criteria, and PTEN. However, our study revealed no correlation between DJ-1 protein and the response to immunotherapy, requiring further research for its use as a predictive biomarker. Regarding Short-Chain Fatty Acids (SCFAs), only butyric acid showed a statistically significant increase in serum concentrations of cancer patients undergoing immunotherapy, with a significant change between two time points. This increase, however, was not correlated with the corresponding response to treatment. Similar results were observed for butyric acid in the subgroup of patients with lung cancer. Finally, Raman spectra analysis, using Silver-Based Plasmonic Nanoparticles, identified the fingerprint peak of the DJ-1 protein, and was noted a decrease in this peak after immunotherapy. In fact, the latter result absolutely matches with ELISA findings, thus making plasmonic substrates and SERS a promising method for bioanalysis and biosensing.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kantzioura, Areti
- Καντζιούρα, Αρετή
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56211